|
|
skeletal system development
|
GO:0001501 |
356 |
0.607
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.596
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.475
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.475
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.425
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.393
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.375
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.333
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.275
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.251
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.236
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.229
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.214
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.207
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.199
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.186
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.186
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.177
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.168
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.165
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.154
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.149
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.127
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.123
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.121
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.116
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.113
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.108
|
|
|
|
neural crest cell migration involved in autonomic nervous system development
|
GO:1901166 |
5 |
0.108
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.106
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.104
|
|
|
|
regulation of cilium assembly
|
GO:1902017 |
7 |
0.101
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.096
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.096
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.093
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.092
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.090
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.090
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.089
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.089
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.088
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.088
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.087
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.086
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.086
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.083
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.083
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.083
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.081
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.081
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.081
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.081
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.079
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.078
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.077
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.077
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.076
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.076
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.073
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.071
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.071
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.071
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.071
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.071
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.070
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.069
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.069
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.069
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.068
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.067
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.067
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.067
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.066
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.066
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.065
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.064
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.064
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.064
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.063
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.063
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.063
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.063
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.063
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.063
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.062
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.061
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.061
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.060
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.060
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.060
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.060
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.059
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.058
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.057
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.057
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.057
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.056
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.056
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.056
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.056
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.055
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.055
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.055
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.054
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.053
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.052
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.052
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.052
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.051
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.051
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.051
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.050
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
25 |
0.050
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.050
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.050
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.050
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.050
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.050
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.050
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.049
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.049
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.049
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.049
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.049
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.049
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.049
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.048
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.048
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.047
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.047
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.047
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.047
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.047
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.046
|
Human |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.046
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.046
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.045
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.045
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.045
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.044
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.044
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.043
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.043
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.043
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.043
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.043
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.043
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.043
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.043
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.042
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.042
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.042
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.042
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.042
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.042
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.042
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.041
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.041
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.041
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.041
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.040
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.040
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.040
|
|
|
|
regulation of male germ cell proliferation
|
GO:2000254 |
3 |
0.040
|
|
|
|
adenine nucleotide transport
|
GO:0051503 |
2 |
0.040
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.040
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.040
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.039
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.039
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.039
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.039
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.039
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.039
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.038
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.038
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.038
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.038
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.038
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.037
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.037
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.037
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.037
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.037
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.037
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.037
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.037
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.036
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.036
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.036
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.036
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.036
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.036
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.036
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.036
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.036
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.035
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.035
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.035
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.035
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.035
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.035
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.035
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.034
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.034
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.034
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.034
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.034
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.034
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.034
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.034
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.034
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.034
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.034
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.034
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.033
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.033
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.033
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.033
|
|
|
|
smoothened signaling pathway involved in dorsal ventral neural tube patterning
|
GO:0060831 |
12 |
0.033
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.033
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.033
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.033
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.032
|
|
|
|
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000164 |
1 |
0.032
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.032
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.032
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.032
|
|
|
|
regulation of tight junction assembly
|
GO:2000810 |
2 |
0.032
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.032
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.032
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.032
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.031
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.031
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.031
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.031
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.031
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
32 |
0.031
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.031
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.031
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.030
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.030
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.030
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.030
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.030
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.030
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.030
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.030
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.029
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.029
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.029
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.029
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.029
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.029
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.029
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.029
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.029
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.029
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.029
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.029
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.029
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.029
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.029
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.029
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.029
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.028
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.028
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.028
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.028
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.028
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.028
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.028
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.028
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.028
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.028
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.028
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.028
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.028
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.028
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.027
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.027
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.027
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.027
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.027
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.027
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.027
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.026
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.026
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.026
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.026
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.026
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.026
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.026
|
|
|
|
intraciliary retrograde transport
|
GO:0035721 |
3 |
0.026
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.026
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.025
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.025
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.025
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.025
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.025
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.025
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.025
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.025
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.025
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.025
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.025
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.025
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.025
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.024
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.024
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.024
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.024
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.024
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.024
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.024
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.024
|
|
|
|
positive regulation of smoothened signaling pathway
|
GO:0045880 |
23 |
0.024
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.023
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
8 |
0.023
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.023
|
|
|
|
hindbrain tangential cell migration
|
GO:0021934 |
2 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.023
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.023
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.023
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.023
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.023
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.023
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.023
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.023
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.023
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.023
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.023
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.023
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.023
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.023
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.023
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.023
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.023
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.023
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.023
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.023
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.023
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.023
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.023
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.023
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.023
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.023
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.023
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.022
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.022
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.022
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.022
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.022
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.022
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.022
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.022
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.022
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.022
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.022
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.022
|
|
|
|
face development
|
GO:0060324 |
38 |
0.021
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.021
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.021
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.021
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.021
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.021
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.021
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.021
|
|
|
|
nonmotile primary cilium assembly
|
GO:0035058 |
8 |
0.021
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.021
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.021
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.021
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.021
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.021
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.021
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.021
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.021
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.020
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
olfactory pit development
|
GO:0060166 |
3 |
0.020
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.020
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.020
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.020
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.020
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.020
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.020
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.020
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.020
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.020
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.020
|
|
|
|
negative regulation of striated muscle cell differentiation
|
GO:0051154 |
14 |
0.020
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.020
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.020
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.020
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.019
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.019
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.019
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.019
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.019
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.019
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.019
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.019
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.019
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.019
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.019
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.019
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.019
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.019
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.019
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.019
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.019
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.018
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.018
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.018
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.018
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.018
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.018
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.018
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.018
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.018
|
|
|
|
embryonic olfactory bulb interneuron precursor migration
|
GO:0021831 |
2 |
0.018
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.018
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.018
|
|
|
|
metanephric nephron tubule formation
|
GO:0072289 |
4 |
0.018
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.018
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.018
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.018
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.018
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.018
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.018
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.018
|
|
|
|
neural crest formation
|
GO:0014029 |
2 |
0.018
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.017
|
|
|
|
germ cell proliferation
|
GO:0036093 |
7 |
0.017
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.017
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.017
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.017
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.017
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.017
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.017
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.017
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.017
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.017
|
|
|
|
translation
|
GO:0006412 |
93 |
0.017
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.017
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.017
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.017
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.017
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.017
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.017
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.017
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.017
|
|
